Global Phenotypic Drug Discovery Market Research Report 2025(Status and Outlook)

September 2025 | 102 pages | ID: G26F251823A1EN
Bosson Research

Abstracts

Phenotypic drug discovery (PDD) refers to an approach in pharmaceutical research where compounds are screened for their effects on observable traits?such as cell morphology, proliferation, or functional outcomes?in whole cells, tissues, or model organisms, without requiring prior knowledge of a specific molecular target; this contrasts with target-based drug discovery, as it allows for the identification of novel mechanisms of action and the discovery of first-in-class therapeutics, particularly in complex diseases where pathophysiology is not fully understood or involves multiple pathways. The global phenotypic drug discovery market is experiencing robust growth, driven by increasing demand for novel therapeutics in areas like oncology, neuroscience, and rare diseases, where target-based approaches have historically faced challenges; technological advancements in high-content screening, automation, and data analytics are enhancing the efficiency and scalability of phenotypic assays, while rising investments from pharmaceutical companies and academic institutions further propel market expansion, though the complexity of data interpretation and higher costs compared to target-based methods remain notable constraints.

The global Phenotypic Drug Discovery market size was estimated at USD 587.45 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Phenotypic Drug Discovery market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Phenotypic Drug Discovery market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Phenotypic Drug Discovery market.

Global Phenotypic Drug Discovery Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris

Market Segmentation (by Type)

Platform
Service

Market Segmentation (by Application)

Cancer
Viral Infection
Genetic Disease
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Phenotypic Drug Discovery Market
Overview of the regional outlook of the Phenotypic Drug Discovery Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phenotypic Drug Discovery Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Phenotypic Drug Discovery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Phenotypic Drug Discovery
1.2 Key Market Segments
  1.2.1 Phenotypic Drug Discovery Segment by Type
  1.2.2 Phenotypic Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PHENOTYPIC DRUG DISCOVERY MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PHENOTYPIC DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Phenotypic Drug Discovery Product Life Cycle
3.3 Global Phenotypic Drug Discovery Revenue Market Share by Company (2020-2025)
3.4 Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Phenotypic Drug Discovery Company Headquarters, Area Served, Product Type
3.6 Phenotypic Drug Discovery Market Competitive Situation and Trends
  3.6.1 Phenotypic Drug Discovery Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Phenotypic Drug Discovery Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PHENOTYPIC DRUG DISCOVERY VALUE CHAIN ANALYSIS

4.1 Phenotypic Drug Discovery Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PHENOTYPIC DRUG DISCOVERY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Phenotypic Drug Discovery Market Porter's Five Forces Analysis

6 PHENOTYPIC DRUG DISCOVERY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Phenotypic Drug Discovery Market Size Market Share by Type (2020-2025)
6.3 Global Phenotypic Drug Discovery Market Size Growth Rate by Type (2021-2025)

7 PHENOTYPIC DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Phenotypic Drug Discovery Market Size (M USD) by Application (2020-2025)
7.3 Global Phenotypic Drug Discovery Sales Growth Rate by Application (2020-2025)

8 PHENOTYPIC DRUG DISCOVERY MARKET SEGMENTATION BY REGION

8.1 Global Phenotypic Drug Discovery Market Size by Region
  8.1.1 Global Phenotypic Drug Discovery Market Size by Region
  8.1.2 Global Phenotypic Drug Discovery Market Size Market Share by Region
8.2 North America
  8.2.1 North America Phenotypic Drug Discovery Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Phenotypic Drug Discovery Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Phenotypic Drug Discovery Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Phenotypic Drug Discovery Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Phenotypic Drug Discovery Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Eurofins Discovery
  9.1.1 Eurofins Discovery Basic Information
  9.1.2 Eurofins Discovery Phenotypic Drug Discovery Product Overview
  9.1.3 Eurofins Discovery Phenotypic Drug Discovery Product Market Performance
  9.1.4 Eurofins Discovery SWOT Analysis
  9.1.5 Eurofins Discovery Business Overview
  9.1.6 Eurofins Discovery Recent Developments
9.2 Sygnature Discovery
  9.2.1 Sygnature Discovery Basic Information
  9.2.2 Sygnature Discovery Phenotypic Drug Discovery Product Overview
  9.2.3 Sygnature Discovery Phenotypic Drug Discovery Product Market Performance
  9.2.4 Sygnature Discovery SWOT Analysis
  9.2.5 Sygnature Discovery Business Overview
  9.2.6 Sygnature Discovery Recent Developments
9.3 PsychoGenics
  9.3.1 PsychoGenics Basic Information
  9.3.2 PsychoGenics Phenotypic Drug Discovery Product Overview
  9.3.3 PsychoGenics Phenotypic Drug Discovery Product Market Performance
  9.3.4 PsychoGenics SWOT Analysis
  9.3.5 PsychoGenics Business Overview
  9.3.6 PsychoGenics Recent Developments
9.4 siTOOLs Biotech
  9.4.1 siTOOLs Biotech Basic Information
  9.4.2 siTOOLs Biotech Phenotypic Drug Discovery Product Overview
  9.4.3 siTOOLs Biotech Phenotypic Drug Discovery Product Market Performance
  9.4.4 siTOOLs Biotech Business Overview
  9.4.5 siTOOLs Biotech Recent Developments
9.5 PhoreMost
  9.5.1 PhoreMost Basic Information
  9.5.2 PhoreMost Phenotypic Drug Discovery Product Overview
  9.5.3 PhoreMost Phenotypic Drug Discovery Product Market Performance
  9.5.4 PhoreMost Business Overview
  9.5.5 PhoreMost Recent Developments
9.6 Charles River
  9.6.1 Charles River Basic Information
  9.6.2 Charles River Phenotypic Drug Discovery Product Overview
  9.6.3 Charles River Phenotypic Drug Discovery Product Market Performance
  9.6.4 Charles River Business Overview
  9.6.5 Charles River Recent Developments
9.7 MaxWell
  9.7.1 MaxWell Basic Information
  9.7.2 MaxWell Phenotypic Drug Discovery Product Overview
  9.7.3 MaxWell Phenotypic Drug Discovery Product Market Performance
  9.7.4 MaxWell Business Overview
  9.7.5 MaxWell Recent Developments
9.8 Arctoris
  9.8.1 Arctoris Basic Information
  9.8.2 Arctoris Phenotypic Drug Discovery Product Overview
  9.8.3 Arctoris Phenotypic Drug Discovery Product Market Performance
  9.8.4 Arctoris Business Overview
  9.8.5 Arctoris Recent Developments

10 PHENOTYPIC DRUG DISCOVERY MARKET FORECAST BY REGION

10.1 Global Phenotypic Drug Discovery Market Size Forecast
10.2 Global Phenotypic Drug Discovery Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Phenotypic Drug Discovery Market Size Forecast by Country
  10.2.3 Asia Pacific Phenotypic Drug Discovery Market Size Forecast by Region
  10.2.4 South America Phenotypic Drug Discovery Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Phenotypic Drug Discovery by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

11.1 Global Phenotypic Drug Discovery Market Forecast by Type (2026-2033)
11.2 Global Phenotypic Drug Discovery Market Forecast by Application (2026-2033)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Phenotypic Drug Discovery Market Size Comparison by Region (M USD)
Table 5. Global Phenotypic Drug Discovery Revenue (M USD) by Company (2020-2025)
Table 6. Global Phenotypic Drug Discovery Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2024)
Table 8. Phenotypic Drug Discovery Company Headquarters and Area Served
Table 9. Company Phenotypic Drug Discovery Product Type
Table 10. Global Phenotypic Drug Discovery Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Phenotypic Drug Discovery Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Phenotypic Drug Discovery Market Size by Type (M USD)
Table 21. Global Phenotypic Drug Discovery Market Size (M USD) by Type (2020-2025)
Table 22. Global Phenotypic Drug Discovery Market Size Share by Type (2020-2025)
Table 23. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (2021-2025)
Table 24. Global Phenotypic Drug Discovery Market Size by Application
Table 25. Global Phenotypic Drug Discovery Market Size by Application (2020-2025) & (M USD)
Table 26. Global Phenotypic Drug Discovery Market Share by Application (2020-2025)
Table 27. Global Phenotypic Drug Discovery Sales Growth Rate by Application (2020-2025)
Table 28. Global Phenotypic Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 29. Global Phenotypic Drug Discovery Market Size Market Share by Region (2020-2025)
Table 30. North America Phenotypic Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Phenotypic Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Phenotypic Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 33. South America Phenotypic Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Phenotypic Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 35. Eurofins Discovery Basic Information
Table 36. Eurofins Discovery Phenotypic Drug Discovery Product Overview
Table 37. Eurofins Discovery Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Eurofins Discovery SWOT Analysis
Table 39. Eurofins Discovery Business Overview
Table 40. Eurofins Discovery Recent Developments
Table 41. Sygnature Discovery Basic Information
Table 42. Sygnature Discovery Phenotypic Drug Discovery Product Overview
Table 43. Sygnature Discovery Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Sygnature Discovery SWOT Analysis
Table 45. Sygnature Discovery Business Overview
Table 46. Sygnature Discovery Recent Developments
Table 47. PsychoGenics Basic Information
Table 48. PsychoGenics Phenotypic Drug Discovery Product Overview
Table 49. PsychoGenics Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 50. PsychoGenics SWOT Analysis
Table 51. PsychoGenics Business Overview
Table 52. PsychoGenics Recent Developments
Table 53. siTOOLs Biotech Basic Information
Table 54. siTOOLs Biotech Phenotypic Drug Discovery Product Overview
Table 55. siTOOLs Biotech Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 56. siTOOLs Biotech Business Overview
Table 57. siTOOLs Biotech Recent Developments
Table 58. PhoreMost Basic Information
Table 59. PhoreMost Phenotypic Drug Discovery Product Overview
Table 60. PhoreMost Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 61. PhoreMost Business Overview
Table 62. PhoreMost Recent Developments
Table 63. Charles River Basic Information
Table 64. Charles River Phenotypic Drug Discovery Product Overview
Table 65. Charles River Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Charles River Business Overview
Table 67. Charles River Recent Developments
Table 68. MaxWell Basic Information
Table 69. MaxWell Phenotypic Drug Discovery Product Overview
Table 70. MaxWell Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 71. MaxWell Business Overview
Table 72. MaxWell Recent Developments
Table 73. Arctoris Basic Information
Table 74. Arctoris Phenotypic Drug Discovery Product Overview
Table 75. Arctoris Phenotypic Drug Discovery Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Arctoris Business Overview
Table 77. Arctoris Recent Developments
Table 78. Global Phenotypic Drug Discovery Market Size Forecast by Region (2026-2033) & (M USD)
Table 79. North America Phenotypic Drug Discovery Market Size Forecast by Country (2026-2033) & (M USD)
Table 80. Europe Phenotypic Drug Discovery Market Size Forecast by Country (2026-2033) & (M USD)
Table 81. Asia Pacific Phenotypic Drug Discovery Market Size Forecast by Region (2026-2033) & (M USD)
Table 82. South America Phenotypic Drug Discovery Market Size Forecast by Country (2026-2033) & (M USD)
Table 83. Middle East and Africa Phenotypic Drug Discovery Market Size Forecast by Country (2026-2033) & (M USD)
Table 84. Global Phenotypic Drug Discovery Market Size Forecast by Type (2026-2033) & (M USD)
Table 85. Global Phenotypic Drug Discovery Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Phenotypic Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Phenotypic Drug Discovery Market Size (M USD), 2024-2033
Figure 5. Global Phenotypic Drug Discovery Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Phenotypic Drug Discovery Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Phenotypic Drug Discovery Product Life Cycle
Figure 12. Global Phenotypic Drug Discovery Revenue Share by Company in 2024
Figure 13. Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Phenotypic Drug Discovery Revenue in 2024
Figure 15. Value Chain Map of Phenotypic Drug Discovery
Figure 16. Global Phenotypic Drug Discovery Market PEST Analysis
Figure 17. Global Phenotypic Drug Discovery Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Phenotypic Drug Discovery Market Share by Type
Figure 20. Market Size Share of Phenotypic Drug Discovery by Type (2020-2025)
Figure 21. Market Size Share of Phenotypic Drug Discovery by Type in 2024
Figure 22. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Phenotypic Drug Discovery Market Share by Application
Figure 25. Global Phenotypic Drug Discovery Market Share by Application (2020-2025)
Figure 26. Global Phenotypic Drug Discovery Market Share by Application in 2024
Figure 27. Global Phenotypic Drug Discovery Sales Growth Rate by Application (2020-2025)
Figure 28. Global Phenotypic Drug Discovery Market Size Market Share by Region (2020-2025)
Figure 29. North America Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Phenotypic Drug Discovery Market Size Market Share by Country in 2024
Figure 31. U.S. Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Phenotypic Drug Discovery Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Phenotypic Drug Discovery Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Phenotypic Drug Discovery Market Share by Country in 2024
Figure 36. Germany Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Phenotypic Drug Discovery Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Phenotypic Drug Discovery Market Size Market Share by Region in 2024
Figure 43. China Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Phenotypic Drug Discovery Market Size and Growth Rate (M USD)
Figure 49. South America Phenotypic Drug Discovery Market Size Market Share by Country in 2024
Figure 50. Brazil Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Phenotypic Drug Discovery Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Phenotypic Drug Discovery Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Phenotypic Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Phenotypic Drug Discovery Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Phenotypic Drug Discovery Market Share Forecast by Type (2026-2033)
Figure 62. Global Phenotypic Drug Discovery Market Share Forecast by Application (2026-2033)